Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
federal funding
Research
Federal mRNA vax grant cuts includes unrelated project
Tiba Biotech's siRNA flu therapeutic was included in the BARDA mRNA vaccine cuts for unclear reasons.
Darren Incorvaia
Aug 7, 2025 2:20pm
HHS cancels mRNA vaccine development funded by BARDA
Aug 5, 2025 7:20pm
Big Pharma-backed program seeks future beyond animal testing
Aug 1, 2025 5:00pm
Federal judge rules hundreds of NIH grant terminations unlawful
Jun 16, 2025 5:55pm
ASH launches $12M fund for scientists who lose federal grants
Jun 10, 2025 4:32pm
NIH staff urge director to reverse funding cuts, firings
Jun 9, 2025 4:33pm
